Spectral AI (MDAI) Liabilities and Shareholders Equity (2021 - 2026)
Spectral AI (MDAI) posted Liabilities and Shareholders Equity of $17.7 million for Q1 2026, down 17.15% on a QoQ basis from $21.4 million in Q4 2025, and down 14.42% year-over-year from $20.7 million in Q1 2025.
Spectral AI (MDAI) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Spectral AI's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $17.7 million for Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 14.42% year-over-year to $17.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.4 million (up 20.8% YoY) and the FY2025 annual result came in at $21.4 million, up 76.97% from the prior year.
- Liabilities and Shareholders Equity was $17.7 million for Q1 2026 at Spectral AI, down from $21.4 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $254.9 million in Q3 2022 and bottomed at $5.3 million in Q2 2023.
- A 5-year average of $56.4 million and a median of $15.5 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity sank 97.91% — and 2024, when it jumped 186.06%.
- Spectral AI's Liabilities and Shareholders Equity stood at $18.7 million in 2022, then sank by 42.87% to $10.7 million in 2023, then rose by 13.12% to $12.1 million in 2024, then jumped by 76.97% to $21.4 million in 2025, then slipped by 17.15% to $17.7 million in 2026.
- Business Quant data shows MDAI's Liabilities and Shareholders Equity at $17.7 million in Q1 2026, $21.4 million in Q4 2025, and $15.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | 13.32 Bn |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 37.13 Bn |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 6.63 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 31.92 Bn |
| 10 | Spectral AI | 52.72 Mn | 41.06 Mn | 2.03 Mn | 17.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.73 Mn |
| Dec 31, 2025 | 21.41 Mn |
| Sep 30, 2025 | 15.30 Mn |
| Jun 30, 2025 | 16.01 Mn |
| Mar 31, 2025 | 20.72 Mn |
| Dec 31, 2024 | 12.10 Mn |
| Sep 30, 2024 | 11.60 Mn |
| Jun 30, 2024 | 13.90 Mn |
| Mar 31, 2024 | 15.48 Mn |
| Dec 31, 2023 | 10.69 Mn |
| Sep 30, 2023 | 12.33 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | 5.41 Mn |
| Dec 31, 2022 | 18.72 Mn |
| Sep 30, 2022 | 254.86 Mn |
| Jun 30, 2022 | 253.88 Mn |
| Mar 31, 2022 | 253.74 Mn |
| Dec 31, 2021 | 254.11 Mn |
| Sep 30, 2021 | 254.29 Mn |
| Jun 30, 2021 | 254.38 Mn |